Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;6(3):103-8.
doi: 10.1177/2042018815577039.

The role of adipokines in gestational diabetes mellitus

Marwa R Al-Badri  1 , Mira S Zantout  1 , Sami T Azar  2
Affiliations
Review

The role of adipokines in gestational diabetes mellitus

Marwa R Al-Badri et al. Ther Adv Endocrinol Metab. 2015 Jun.

Abstract

Gestational diabetes mellitus (GDM) is a complication of pregnancy that is characterized by impaired glucose tolerance with onset or first recognition during pregnancy. The reported prevalence of GDM varies between 0.6% and 20% of pregnancies depending on screening method, gestational age and the population studied. GDM is characterized by pancreatic β-cell function that is insufficient to meet the body's insulin needs. Available evidence suggests that β-cell defects in GDM result from the same spectrum of causes that underline hyperglycemia in general, including autoimmune disease, monogenic causes and insulin resistance. Adipokines are proteins secreted from the adipocytes and are believed to have a metabolic influence. Our review suggests that, in GDM, various adipokines, mainly leptin and adiponectin, are dysregulated. These two adipokines might have both prognostic and pathophysiological significance in this disease.

Keywords: adipokines; adiponectin; gestational diabetes; insulin resistance; leptin; β cell.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest in preparing this article.

Figures

Figure 1.
Figure 1.
Demonstrating the role of adiponectin in gestational diabetes. GDM, gestational diabetes mellitus; IL-6, interleukin 6; TNFα, tumour necrosis factor-α.
Figure 2.
Figure 2.
Demonstrating the role of leptin in gestational diabetes. GDM, gestational diabetes mellitus; IL-6, interleukin 6; TNFα, tumour necrosis factor-α.
See this image and copyright information in PMC

References

    1. Ballesteros M., Simón I., Vendrell J., Ceperuelo-Mallafré V., Miralles R., et al. (2011) Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care 34: 2418–2423. - PMC - PubMed
    1. Buchanan T., Xiang A. (2005) Gestational diabetes mellitus. J Clin Invest 115: 485–491. - PMC - PubMed
    1. Desoye G., Hauguel-de Mouzon S. (2007) The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 30(Suppl. 2): S120–S126. - PubMed
    1. Doruk M., Uğur M., Oruç A., Demirel N., Yildiz Y. (2014) Serum adiponectin in gestational diabetes and its relation to pregnancy outcome. J Obstet Gynaecol 34: 471–475. - PubMed
    1. Georgiou H., Lappas M., Georgiou G., Marita A., Bryant V., Hiscock R., et al. (2008) Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 45: 157–165. - PubMed

LinkOut - more resources